// App-Quantinova.ai

20 : Evidence for altered peroxisome proliferator activated receptor (PPAR) pathway activity in a transgenic mouse model of scleroderma (TbRIIDk-fib): analysis of mouse skin, lung and explanted cells

Researchers

Presenter

  • Emma Derrett-Smith

Principal Investigators

  • Rachel Hoyles

  • Xu Shi-Wen

  • Olivier Lacombe

  • Pierre Broqua

  • Jean-Louis Junien

  • Irena Konstantinova

  • Christopher P Denton

Medical Centers

  • Rheumatology, Division of Medicine, London, UNITED KINGDOM

  • Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

  • Inventiva, Inventiva, Daix, FRANCE

Locations

  • United Kingdom

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • Peroxisome proliferator activated receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved